tiprankstipranks
Advertisement
Advertisement

MDWD Stock Latest News

MediWound Shareholders Back Board, Auditor and CEO Bonus at 2026 Annual Meeting
Company AnnouncementsMediWound Shareholders Back Board, Auditor and CEO Bonus at 2026 Annual Meeting
15d ago
6K
MDWD
MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market
PremiumTipRanks Newswire
MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market
28d ago
CPIX
MDWD
MediWound: EscharEx Phase III Upside and NexoBrid Traction Support Compelling Buy Thesis
PremiumRatings
MediWound: EscharEx Phase III Upside and NexoBrid Traction Support Compelling Buy Thesis
1M ago
MDWD
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid
PremiumCompany Announcements
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid
2M ago
6K
MDWD
MediWound says Vericel awarded ten-year contract valued at up to $197M
PremiumThe Fly
MediWound says Vericel awarded ten-year contract valued at up to $197M
2M ago
MDWD
VCEL
MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus
PremiumCompany AnnouncementsMediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus
2M ago
6K
MDWD
MediWound management to meet with Maxim
Premium
The Fly
MediWound management to meet with Maxim
2M ago
MDWD
MediWound Is the Biotech Governments Have Been Stockpiling for Exactly These Kinds of Wars (NASDAQ: MDWD)
Premium
TipRanks Newswire
MediWound Is the Biotech Governments Have Been Stockpiling for Exactly These Kinds of Wars (NASDAQ: MDWD)
2M ago
ESLT
KTOS
MediWound Earnings Call Balances Setbacks and Expansion
PremiumCompany Announcements
MediWound Earnings Call Balances Setbacks and Expansion
2M ago
MDWD
MediWound: BARDA Contract Reinstatement, Capacity Expansion, and EscharEx Pipeline Catalysts Support Long-Term Buy Thesis
PremiumRatings
MediWound: BARDA Contract Reinstatement, Capacity Expansion, and EscharEx Pipeline Catalysts Support Long-Term Buy Thesis
3M ago
MDWD
Buy Rating Backed by Temporary Q4 Disruption, Long-Term Government Contracts, and NexoBrid-Driven Growth
PremiumRatings
Buy Rating Backed by Temporary Q4 Disruption, Long-Term Government Contracts, and NexoBrid-Driven Growth
3M ago
MDWD
MediWound Posts 2025 Loss but Strengthens Cash and Advances EscharEx, NexoBrid Capacity
PremiumCompany Announcements
MediWound Posts 2025 Loss but Strengthens Cash and Advances EscharEx, NexoBrid Capacity
3M ago
6K
MDWD
MediWound reports Q4 EPS (56c), consensus (61c)
PremiumThe FlyMediWound reports Q4 EPS (56c), consensus (61c)
3M ago
MDWD
MediWound sees FY26 revenue $24M-$26M, consensus $26.21M
Premium
The Fly
MediWound sees FY26 revenue $24M-$26M, consensus $26.21M
3M ago
MDWD
MediWound sees FY27 revenue $32M-$35M, sees FY28 revenue $50M-$55M
Premium
The Fly
MediWound sees FY27 revenue $32M-$35M, sees FY28 revenue $50M-$55M
3M ago
MDWD
MediWound management to meet with Maxim
PremiumThe Fly
MediWound management to meet with Maxim
3M ago
MDWD
Is MDWD a Buy, Before Earnings?
PremiumPre-Earnings
Is MDWD a Buy, Before Earnings?
3M ago
MDWD
MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool
PremiumCompany Announcements
MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool
3M ago
6K
MDWD
MediWound Calls February 19, 2026 Extraordinary Meeting to Expand 2024 Share Incentive Plan
PremiumCompany Announcements
MediWound Calls February 19, 2026 Extraordinary Meeting to Expand 2024 Share Incentive Plan
4M ago
6K
MDWD
Mediwound: NexoBrid Capacity Expansion and EscharEx Pipeline Catalysts Support Buy Rating and $36 Target
PremiumRatingsMediwound: NexoBrid Capacity Expansion and EscharEx Pipeline Catalysts Support Buy Rating and $36 Target
4M ago
MDWD
MediWound Lays Out Growth Path With EscharEx Progress, NexoBrid Scale-Up and Strong Cash Position
Premium
Company Announcements
MediWound Lays Out Growth Path With EscharEx Progress, NexoBrid Scale-Up and Strong Cash Position
4M ago
6K
MDWD
MediWound sees FY25 revenue $17M, consensus $22.98M
Premium
The Fly
MediWound sees FY25 revenue $17M, consensus $22.98M
4M ago
MDWD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >